These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26438672)

  • 1. Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.
    Golomb BA; Koslik HJ; Redd AJ
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolone-associated tendinopathy.
    Tsai WC; Yang YM
    Chang Gung Med J; 2011; 34(5):461-7. PubMed ID: 22035890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone use in a rural practice.
    Kelly L; Schreiber YS; Hopko J; Kirkwood T; Kattini R; Poirier D; Madden S
    Can J Rural Med; 2021; 26(1):14-18. PubMed ID: 33380601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone-induced tendinopathy: etiology and preventive measures.
    Kaleagasioglu F; Olcay E
    Tohoku J Exp Med; 2012 Apr; 226(4):251-8. PubMed ID: 22452935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between oral fluoroquinolones and seizures: A self-controlled case series study.
    Chui CS; Chan EW; Wong AY; Root A; Douglas IJ; Wong IC
    Neurology; 2016 May; 86(18):1708-15. PubMed ID: 27053716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of fluoroquinolone-induced tendon disorders using a hospital database in Japan.
    Hori K; Yamakawa K; Yoshida N; Ohnishi K; Kawakami J
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):886-9. PubMed ID: 22532516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study.
    Etminan M; Brophy JM; Samii A
    Neurology; 2014 Sep; 83(14):1261-3. PubMed ID: 25150290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do fluoroquinolones commonly cause arthropathy in children?
    Forsythe CT; Ernst ME
    CJEM; 2007 Nov; 9(6):459-62. PubMed ID: 18072993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study.
    Kuo SC; Chen YT; Lee YT; Fan NW; Chen SJ; Li SY; Liu CJ; Chen TL; Chen TJ; Fung CP
    Clin Infect Dis; 2014 Jan; 58(2):197-203. PubMed ID: 24170197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What tendon pathology is seen on imaging in people who have taken fluoroquinolones? A systematic review.
    Lang TR; Cook J; Rio E; Gaida JE
    Fundam Clin Pharmacol; 2017 Feb; 31(1):4-16. PubMed ID: 27477928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012.
    Almalki ZS; Alahmari AK; Guo JJ; Cavanaugh TM
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1042-51. PubMed ID: 27133913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone-Associated Tendinopathy: Does Levofloxacin Pose the Greatest Risk?
    Bidell MR; Lodise TP
    Pharmacotherapy; 2016 Jun; 36(6):679-93. PubMed ID: 27138564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reoccurrence of levofloxacin-induced tendinitis by phenoxymethylpenicillin therapy after 6 months: a rare complication of fluoroquinolone therapy?
    Schindler C; Pittrow D; Kirch W
    Chemotherapy; 2003 May; 49(1-2):90-1. PubMed ID: 12756981
    [No Abstract]   [Full Text] [Related]  

  • 14. Diplopia and fluoroquinolones.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Third and fourth generation fluoroquinolone antibacterials: a systematic review of safety and toxicity profiles.
    Sousa J; Alves G; Fortuna A; Falcão A
    Curr Drug Saf; 2014; 9(2):89-105. PubMed ID: 24410307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study.
    Inghammar M; Svanström H; Melbye M; Pasternak B; Hviid A
    BMJ; 2016 Feb; 352():i843. PubMed ID: 26920666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Systemic and Topical Fluoroquinolones.
    Jackson MA; Schutze GE;
    Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musculoskeletal complications of fluoroquinolones: guidelines and precautions for usage in the athletic population.
    Hall MM; Finnoff JT; Smith J
    PM R; 2011 Feb; 3(2):132-42. PubMed ID: 21333952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Warning for Fluoroquinolone Antibiotics.
    Aschenbrenner DS
    Am J Nurs; 2019 Apr; 119(4):20. PubMed ID: 30896484
    [No Abstract]   [Full Text] [Related]  

  • 20. Intractable Acute Pain Related to Fluoroquinolone-Induced Peripheral Neuropathy.
    Dukewich M; Danesh A; Onyima C; Gupta A
    J Pain Palliat Care Pharmacother; 2017 Jun; 31(2):144-147. PubMed ID: 28358229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.